News Conference News ACC 2018 Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News ACC 2018 Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ACC 2018 Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Conference News ACC 2017 CMR Perfusion Imaging Holds Its Own Against Invasive Approach to Managing Stable Angina Todd Neale March 22, 2017
News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017
News Conference News ACC 2017 FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI Todd Neale March 18, 2017
News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions Caitlin E. Cox March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2017 Down and Out: Depressed CAD Patients Twice as Likely to Die as Those Without Depression L.A. McKeown March 09, 2017